New initiative aims to transform how Alzheimer’s disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science, and precision medicine.

How Physician Groups Can Fight Back Against Private Equity

Nathaniel Arana, CEO at NGA Healthcare As a society, we should all be concerned about the increasing rate at which private equity firms are acquiring

February 20, 2024

Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios

The FDA approved a new treatment for a rare form of brain cancer whose tumors have a mutation that drives the disease. Tuesday’s approval of

August 7, 2024

Ubiquigent and Debiopharm enter agreement to support USP1 inhibitor programme for Debio 0432

Project will be a demonstration of how Ubiquigent’s DUB-centric platform can support the development of DUB inhibitors all the way from discovery through to clinical

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.